Comparison of door-to-needle time of tenecteplase versus alteplase for acute ischemic stroke
Am J Emerg Med
.
2023 Jan:63:158-160.
doi: 10.1016/j.ajem.2022.09.030.
Epub 2022 Sep 28.
Authors
Sidney Aviles Dimova
1
,
Elizabeth S Levins
1
,
Emilie D Bode
2
,
Nathan D Mah
3
Affiliations
1
Department of Pharmacy Services, Oregon Health & Science University, Portland, OR, USA.
2
Oregon Stroke Center, Oregon Health & Science University, Portland, OR, USA.
3
Department of Pharmacy Services, Oregon Health & Science University, Portland, OR, USA. Electronic address: ndmah@lhs.org.
PMID:
36192247
DOI:
10.1016/j.ajem.2022.09.030
No abstract available
Publication types
Letter
MeSH terms
Humans
Ischemic Stroke*
Tenecteplase / therapeutic use
Tissue Plasminogen Activator* / therapeutic use
Substances
Tenecteplase
Tissue Plasminogen Activator